Delek US EVP sells 10,000 shares at $68.21

Delek US Holdings, Inc. (DK) reported that executive vice president, Special Projects, Reuven Spiegel filed a Form 4 for one open-market sale of 10,000 shares of common stock on August 18, 2026 at $68.21 per share.

Rhea-AI Filing Summary

Delek US Holdings, Inc. (DK) reported that executive vice president, Special Projects, Reuven Spiegel filed a Form 4 for one open-market sale of 10,000 shares of common stock on August 18, 2026 at $68.21 per share. After this transaction, he directly holds 36,435 shares. The sale was made pursuant to a Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Spiegel Reuven

Role EVP, Special Projects

Sold 10,000 shs ($682K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10,000	$68.21	$682K

Holdings After Transaction: Common Stock — 36,435 shares (Direct)

Footnotes (1)

1. F1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Key Figures

Shares sold: 10,000 shares of Common Stock Sale price per share: $68.21 per share Shares held after transaction: 36,435 shares +2 more

5 metrics

Shares sold 10,000 shares of Common Stock Open-market or private sale on August 18, 2026

Sale price per share $68.21 per share Price for the 10,000 DK shares sold on August 18, 2026

Shares held after transaction 36,435 shares Direct ownership by Reuven Spiegel following the sale

Net shares sold in filing 10,000 shares transactionSummary netBuySellShares reported as -10,000

Number of sell transactions 1 transaction transactionSummary shows 1 sale and no purchases

Key Terms

Rule 10b5-1 plan, affirmative defense conditions, Form 4

3 terms

Rule 10b5-1 plan regulatory

"This transaction was made pursuant to a 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

affirmative defense conditions regulatory

"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)"

Form 4 regulatory

"executive vice president, Special Projects, Reuven Spiegel filed a Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DK report for Reuven Spiegel?

Delek US Holdings, Inc. reported that EVP, Special Projects, Reuven Spiegel sold 10,000 shares of common stock in an open-market or private transaction on August 18, 2026.

At what price were Delek US Holdings (DK) shares sold in this Form 4?

The reported sale by Reuven Spiegel was executed at a price of $68.21 per share for Delek US Holdings, Inc. common stock.

How many DK shares does Reuven Spiegel hold after this transaction?

Following the reported sale, Reuven Spiegel directly holds 36,435 shares of Delek US Holdings, Inc. common stock.

Was the DK insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

How many total DK shares were sold in this Form 4 filing?

The Form 4 reports a single transaction in which 10,000 shares of Delek US Holdings, Inc. common stock were sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/20/2026 - 08:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spiegel Reuven

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Special Projects

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2026		S		10,000(1)	D	$68.21	36,435	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

	/s/ Reuven Spiegel	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)